Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 01:35:55 - browse：3

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Doctor appointment wait times are getting worse

WSS

Make 'food is medicine' a key part of White House nutrition meeting

Grail is spending more than ever lobbying Congress

Meta looks to target Twitter with a rival app called Threads

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Connecting traumatic brain injury and domestic violence

Boston hospital trains restaurant workers on naloxone for overdoses

hotspot

Wikipedia

focus

Medicare proposal to cover medical devices draws a mixed reaction

Australia's humpback populations rebound raising hopes of marine scientists

Psychedelics group wrestles with new pharma identity

Brain 'hot spot' may explain why African Americans feel greater pain

United colonoscopy coverage change 'may cost lives,' doctors say

Inside the fall of star MIT scientist David Sabatini

Wildfire smoke exposes gaps in outdoor worker protections

Inside the fall of star MIT scientist David Sabatini

New air purifier tech could be key to improving indoor air quality

Lilly’s weekly insulin works as well as daily products, new studies show

knowledge

PhRMA sues HHS over Medicare drug price negotiation

Pfizer's Covid pill remains 89% effective in final analysis, company says

PhRMA sues HHS over Medicare drug price negotiation

PhRMA sues HHS over Medicare drug price negotiation

Did the public have the right to know Arthur Ashe had AIDS?

RaDonda Vaught case: a double standard for nurses, physicians

knowledge

knowledge

focus

focus